Eagle Pharmaceuticals
BELRAPZO
Manufacturer:
Eagle Pharmaceuticals
Name:
BELRAPZO
Category:
J Code
HCPCS:
J9036
NDC(s):
10019-0079-01, 42367-0520-25, 42367-0521-25,
Primary Type:
Cancer
Route of Administration:
Intravenous
About:
BELRAPZO is a Cancer drug manufactured by Eagle Pharmaceuticals and administered via the Intravenous route of administration. The J Code: J9036 is aligned to the drug BELRAPZO.